TGFB1 and endometrial cancer: Chen et al. [96] reported that Isoliqueritigenin (ISL), a flavonoid derived from liquorice and bean sprouts, may be able to reverse TGF-β-induced EMT changes in endometrial cancer cell lines, causing it to be a potential candidate for targeting TGF-β-induced signalling in endometrial cancer.